TNB-409

N/A

Report date: 2025/07/03 16:42:46

Base Information

Drug NameTNB-409

Drug Alias NameTNB-409

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-2 receptor agonists

TargetsInterleukin-2 receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTeneobio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTeneobio Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A